Government announces subscription and allocation results of Silver Bond

Source: Hong Kong Government special administrative region – 4

The Government announced today (October 8) the subscription and allocation results of the new batch of Silver Bond.
 
According to the subscription information submitted by the Placing Banks and the Designated Securities Brokers, as at the close of the subscription period on September 29, 2025, a total of 371,821 valid applications were received for a total of HK$98,227,300,000 in principal amount of bonds.
 
The final issuance amount of the Silver Bond will be HK$55 billion, higher than the target issuance amount of HK$50 billion. Allocation is conducted in accordance with the mechanism set out in the Issue Circular. All valid applications received have been allocated bonds up to a maximum of 17 units (with each unit being HK$10,000). For the 89,958 applications seeking 16 or fewer units, they will be allocated the full amounts applied for. The remaining 281,863 applications applying for more than 16 units will be allocated 16 units each and then entered into a ballot. Of these applications, 113,918 will be allocated one additional unit.
 
The Silver Bond will be issued on October 10, 2025, under the retail part of the Infrastructure Bond Programme. Notifications on individual allocation results, applicable subscription moneys and refund of application moneys in excess of the allocated portion will be sent to applicants.
 
The Financial Secretary, Mr Paul Chan, said, “Both the number of applicants and subscription amount for this batch of Silver Bond have reached record highs, demonstrating that Silver Bond continues to be widely welcomed by the public. Silver Bond provides a safe, reliable and low-risk investment option with steady returns for senior citizens, while supporting infrastructure projects for the good of the economy and people’s livelihoods at the same time. It provides members of the public with a greater ‘sense of participation’ and ‘sense of gain’ in support of infrastructure projects for Hong Kong’s long-term development. We will keep the Silver Bond scheme under review, taking account of investor response, market conditions and other relevant considerations.”

CE to attend flame-lighting ceremony of 15th National Games, 12th National Games for Persons with Disabilities and 9th National Special Olympic Games in Nansha, Guangzhou

Source: Hong Kong Government special administrative region – 4

The Chief Executive, Mr John Lee, will depart for Nansha, Guangzhou, tomorrow morning (October 9) to attend the flame-lighting ceremony of the 15th National Games (NG), the 12th National Games for Persons with Disabilities (NGD) and the 9th National Special Olympic Games (NSOG).
 
Mr Lee will be an officiating guest at the ceremony and will light the flame for the 15th NG, the 12th NGD and the 9th NSOG on behalf of the Hong Kong Special Administrative Region. The Vice President and Secretary-General of the Organising Committee of the 15th NG, the 12th NGD and the 9th NSOG and Chief Secretary for Administration, Mr Chan Kwok-ki, will receive the flame of the 15th NG, the 12th NGD and the 9th NSOG.
 
     Guangdong, Hong Kong and Macao will be presented with the flame of the 15th NG, the 12th NGD and the 9th NSOG at the ceremony, symbolising their cohosting of the Games.

Mr Lee will return to Hong Kong the same afternoon.

Hong Kong Customs launches pilot run for duty stamp system for three months (with photos)

Source: Hong Kong Government special administrative region – 4

According to the Dutiable Commodities Ordinance (Cap. 109) amended by the Government of the Hong Kong Special Administrative Region through the Tobacco Control Legislation (Amendment) Ordinance 2025, the duty stamp system will be implemented to help distinguish between duty-paid and duty-not-paid cigarettes. Hong Kong Customs launched a three-month pilot run for the duty stamp system on October 6 and plans to implement the first phase of the system in the fourth quarter of 2026, followed by full implementation in the second quarter of 2027.
 
     The pilot run for the duty stamp system aims to simulate workflow and technology in practical operations to evaluate their effectiveness and feasibility, as well as to promote industry and public awareness of the key features of the system that enable them to prepare related compliance in advance.
 
     In the first phase of the pilot run, Customs officers at Duty Collection Offices of designated control points, namely the Lok Ma Chau Spur Line Control Point, the Hong Kong-Zhuhai-Macao Bridge Hong Kong Port and selected cargo terminals of Hong Kong International Airport, will affix a trial duty stamp to each unopened retail package of cigarettes brought into Hong Kong by incoming passengers or imported for single shipments upon full duty payment. Meanwhile, local tobacco manufacturers are also invited to join the pilot run and affix trial duty stamps to retail packages of cigarettes intended for local sale. Therefore, cigarettes that bear the trial duty stamps will be supplied on the market later.
 
     The trial duty stamps are designed to bear both physical and digital anti-counterfeiting features. Customs officers and members of the public can scan the encrypted QR code on the trial duty stamp using dedicated devices available at the designated control points or retail outlets to ascertain the duty-paid status of the cigarettes. For easy identification, trial duty stamps affixed by Customs officers and local manufacturers are respectively in blue and green colours.
 
     Participation in the pilot run is voluntary. Hong Kong Customs welcomes the public to give suggestions and views on the pilot run through questionnaires. After the mid-term evaluation, Hong Kong Customs will extend the pilot run to more Duty Collection Offices at various control points.

Silver Bond allocations announced

Source: Hong Kong Information Services

The subscription and allocation results for the latest batch of Silver Bonds were released today.

A total of 371,821 valid applications, seeking $98.2 billion in bond principals, were received.

Of the applications received, 89,958 were for 16 units or fewer. These applicants will be allocated the full amounts they applied for.

The remaining 281,863 applications were for more than 16 units. These applicants will be allocated 16 units each, with 113,918 being allocated one additional unit following a ballot.

The bonds will be issued on Friday and the final issuance amount will be $55 billion.

Financial Secretary Paul Chan highlighted that both the number of applicants and the subscription amount for this round of bonds represented record highs, demonstrating that there is strong demand for the Silver Bond scheme.

He said it provides a safe, reliable and low-risk investment option with steady returns for senior citizens, while also supporting infrastructure projects for the good of the economy and people’s livelihoods.

“We will keep the scheme under review, taking account of investor response, market conditions and other relevant considerations,” he added.

CE to attend games flame-lighting

Source: Hong Kong Information Services

Chief Executive John Lee will attend the flame-lighting ceremony of the 15th National Games (NG), the 12th National Games for Persons with Disabilities (NGD) and the 9th National Special Olympic Games (NSOG), in Nansha, Guangzhou tomorrow.

At the ceremony, Mr Lee will be an officiating guest to light the flame for the 15th NG, the 12th NGD and the 9th NSOG on behalf of the Hong Kong Special Administrative Region.

Vice President and Secretary-General of the Organising Committee of the 15th NG, the 12th NGD & the 9th NSOG, and Chief Secretary Chan Kwok-ki, will receive the flame of the games.

Guangdong, Hong Kong and Macau will be presented with the flame to symbolise the three places cohosting the games.

Mr Lee will depart for the ceremony tomorrow morning and return to Hong Kong that afternoon.

Three incoming passengers convicted and jailed for importing prohibited articles not under and in accordance with import licence (with photo)

Source: Hong Kong Government special administrative region – 4

     Hong Kong Customs on September 2 detected a smuggling case involving three passengers at Hong Kong International Airport (HKIA) and seized 6 517 pieces of pharmaceutical injections containing Part I Poisons and 600 tablets of pharmaceutical products containing Part I Poisons with an estimated market value of about $4.7 million. The three passengers concerned were convicted and sentenced to three months’ imprisonment by the West Kowloon Magistrates’ Courts today (October 8) for contravening the Import and Export Ordinance (IEO) (Cap. 60).
 
     Customs officers intercepted the three male passengers, aged 55, 51 and 39 on September 2 at the Arrival Hall at HKIA for Customs clearance. Upon examination, the batch of pharmaceutical injections and pharmaceutical products was found inside their check-in suitcases.
    
     Customs reminds the public not to carry controlled items into and out of Hong Kong.
 
     Under the IEO, any person who imports pharmaceutical products and medicines without a valid import licence commits an offence. The maximum penalty upon conviction is a fine of $2 million and imprisonment for seven years.
 
     Members of the public may report any suspected smuggling activities to Customs’ 24-hour hotline 182 8080 or its dedicated crime-reporting email account (crimereport@customs.gov.hk) or online form (eform.cefs.gov.hk/form/ced002).

  

LCQ7: Sales model of “blind boxes”

Source: Hong Kong Government special administrative region – 4

     Following is a question by Dr the Hon Hoey Simon Lee and a written reply by the Secretary for Commerce and Economic Development, Mr Algernon Yau, in the Legislative Council today (October 8):

Question:

     It is learnt that in recent years, the sale of products in the form of “blind boxes” (i.e. commodities whose contents are unidentifiable by consumers in advance) has become increasingly common among some merchants. However, such sales model has also aroused consumers’ concerns about their rights and interests as well as its impact on minors. In this connection, will the Government inform this Council:

(1) whether the authorities have regulated the sales model of “blind boxes” under the current legal and regulatory framework;

(2) as there are views that under the sales model of “blind boxes”, consumers are more inclined to pursue the thrill and chance-taking mentality from not being able to identify the contents of the “blind box” items in advance rather than the items themselves, whether the Government has assessed the gambling elements that may be inherent in the sales model of “blind boxes” and its impact on minors;

(3) it is learnt that some European Union countries, Singapore and the Mainland have imposed regulation on the sale of “blind boxes”, whether the authorities will consider drawing on the experience of the aforesaid countries to improve the current regulatory framework for the sales model of “blind boxes”;

(4) it is learnt that in addition to “blind boxes” available for sale offline, consumers can also purchase “blind boxes” sold outside Hong Kong through online platforms, whether the authorities have assessed if the existing legislation and regulation are sufficient to guard against such risks relating to tax avoidance and prohibited articles that may be associated with “blind boxes” sold outside Hong Kong; and

(5) as the State Administration for Market Regulation issued the Guidelines on Rules for Blind Box Business Operations (for Trial Implementation) in June 2023, which include a specific negative sales list prohibiting the sale of certain commodities such as medicinal products, medical devices as well as flammables and explosives in the form of “blind boxes”, while also imposing restrictions on products such as cosmetics and food that have a bearing on public health, whether the Government will consider drawing on such practice to regulate the sales practice of commodities relating to public health and safety?

Reply:

President,

     Having consulted the Home Affairs and Youth Bureau, the Health Bureau, the Environment and Ecology Bureau, the Security Bureau, the Financial Services and the Treasury Bureau, and the Hong Kong Customs and Excise Department (C&ED), our consolidated reply to various parts of the question is as follows:

     The Government has been committed to safeguarding the rights and interests of consumers, and attaches great importance to the safety of products sold in the market. Regarding “blind boxes” which have gained popularity in recent years, we note that other jurisdictions, including the Mainland, have been regulating, among others, relevant sales practices and product safety.

     Currently, various laws are in place in Hong Kong to protect the rights and interests of consumers. Among others, the Trade Descriptions Ordinance (Cap. 362) prohibits traders from subjecting consumers to unfair trade practices, including false trade descriptions, misleading omissions, aggressive commercial practices, bait advertising, bait-and-switch and wrongly accepting payment. The Trade Descriptions Ordinance covers goods and services, and is applicable to the trade practices of both physical and online traders. A trader deploying any of the above unfair trade practices when selling “blind boxes” to consumers will contravene the law.

     The C&ED, as the principal enforcement agency of the Trade Descriptions Ordinance, has been actively combating unfair trade practices through enforcement actions, compliance promotion, and publicity and public education, with a view to protecting consumer rights and interests. If a trader is suspected of having engaged in unfair trade practices, the C&ED will take enforcement actions decisively. On the other hand, the Consumer Council endeavours to study and promote the protection of consumers’ rights and interests, including handling consumer complaints concerning goods and services. If consumers suspect that a trader is engaging in unfair trade practices when selling “blind boxes”, they could report the matter to the C&ED or file a complaint with the Council.

     In addition, at present, various laws in Hong Kong regulate the safety of different types of products or articles. Any person supplying relevant products or articles to consumers, regardless of the form, packaging and sales channel, is responsible for ensuring that their safety complies with the relevant legal requirements.

     In respect of toys products, the Toys and Children’s Products Safety Ordinance (Cap. 424) regulates the safety of toys, which are manufactured, imported or supplied for local use. The Toys and Children’s Products Safety (Additional Safety Standards or Requirements) Regulation also stipulates that a toy supplied in Hong Kong must carry information including identification markings (i.e. the full name and address of the manufacturer, importer or supplier) and the bilingual warnings or cautions (with respect to the safe keeping, use, consumption or disposal) applicable to the toy.

     For drugs (including pharmaceutical products and proprietary Chinese medicines (pCms)), the current regulations aim to ensure that drugs meet relevant standards for safety, quality and efficacy, thereby safeguarding public health and safety. They must be registered under the Pharmacy and Poisons Ordinance (Cap. 138) (PPO) or the Chinese Medicine Ordinance (Cap. 549) before they can be sold. All registered pharmaceutical products and pCms must bear labels that correspond to the registration particulars, clearly stating information such as the Hong Kong registration number, product name, active ingredients, manufacturer information, etc. Selling drugs in the form of “blind boxes” may violate relevant legislation. When purchasing drugs, members of the public should carefully read the information on the packaging labels, and should not buy or use products of doubtful composition or from unknown sources.

     As regards medical devices, some products are already regulated by existing legislation, including the PPO, the Consumer Goods Safety Ordinance (Cap. 456) and the Trade Descriptions Ordinance etc, depending on the characteristics and features of the products concerned. Before purchasing and using medical devices, members of the public should also thoroughly familiarise themselves with the product to ensure it meets their needs. The Government is actively developing Hong Kong into an international health and medical innovation hub, and will set up the Hong Kong Centre for Medical Products Regulation in 2026, implement “primary evaluation” for new drug registration in phases and submit a legislative proposal on regulating medical devices, to enhance medical products regulation.

     As regards dangerous goods, the Dangerous Goods Ordinance (Cap. 295) and its subsidiary legislation regulate the manufacture, storage, conveyance and use of dangerous goods (including explosives and inflammable substances). A trader supplying any dangerous goods regulated under the above legislation in the form of “blind boxes” must comply with the legal requirements. If the articles inside the “blind boxes” are commonly used in daily life and available in retail stores (such as alcohol handrub/sanitiser, glue, etc), and the container sizes of which do not exceed the maximum package size specified in the Dangerous Goods (Application and Exemption) Regulation 2012, they are classified as dangerous goods in consumer packs, and will be exempted from the packing, marking and labelling requirements.

     As regards food, according to the Public Health and Municipal Services Ordinance (Cap. 132), all food sold in Hong Kong shall be safe for human consumption. It must also comply with the subsidiary legislation under the aforementioned ordinance concerning food safety and food safety standards. Specifically, according to the Food and Drugs (Composition and Labelling) Regulations, unless exempted, the labelling or marking of the prepackaged food for sale in Hong Kong, whether in the form of “blind boxes” or not, must include relevant information, including indication of durability, statement of special conditions for storage or instructions for use, information on energy value and nutrient content, etc, in either the English or the Chinese language or in both languages.

     Moreover, the safety of consumer goods which are ordinarily supplied for private use in Hong Kong, if not covered by other legislation, is subject to the regulation of the Consumer Goods Safety Ordinance and its subsidiary legislation, the Consumer Goods Safety Regulation. Pursuant to the Consumer Goods Safety Ordinance, manufacturers, importers and suppliers should ensure that the consumer goods they supply are reasonably safe. The Consumer Goods Safety Regulation stipulates that any warning or caution marked on the package of consumer goods must be in both the English and the Chinese languages in a legible and conspicuous manner.

     The Government will continue to closely monitor the trends of unfair trade practices and the latest requirements for safety standards of various articles to formulate appropriate strategies, thereby protecting consumers’ rights and interests and safety.

     Furthermore, there are strict regulations in Hong Kong on the import and export of all prohibited/controlled items and dutiable commodities. These regulations are applicable to all modes of import and export, including articles purchased through cross-border electronic commerce platforms. According to the Import and Export Ordinance (Cap. 60), import and export of all controlled items (including dangerous drugs, arms, ammunition, weapons, controlled chemicals, pharmaceuticals, and animals and plants, etc) must be accompanied by a valid licence or permit issued by the relevant authorities. Any person who brings any controlled item into/out of Hong Kong (whether by person, by post, or through purchasing agents or consolidated consignments) without a valid licence or permit may be prosecuted, in addition to confiscation of the subject item. In terms of tax, apart from four categories of dutiable commodities that are subject to duty under the Dutiable Commodities Ordinance (Cap. 109) (i.e. liquor, tobacco, hydrocarbon and methyl alcohol), Hong Kong does not impose duty on any other imported or exported goods. Any person who imports or exports dutiable goods must obtain a valid permit from the C&ED and make proper declaration on the manifest. For consumption of dutiable goods in Hong Kong, one must ensure that the relevant duty has been duly paid.

Monthly gravidtrap index for Aedes albopictus mosquitoes continues to drop in September

Source: Hong Kong Government special administrative region – 4

     The Food and Environmental Hygiene Department (FEHD) today (October 8) announced that the monthly gravidtrap index (MGI) for Aedes albopictus mosquitoes in September was 2.5 per cent, lower than the 5.3 per cent in August. This reflects the continued efforts by relevant government departments to intensify mosquito prevention and elimination operations, resulting in the improvement of the overall mosquito infestation situation this month. In addition, the FEHD has strengthened the dissemination of information on the gravidtrap index for Aedes albopictus mosquitoes so that more citizens can quickly grasp the mosquito infestation situation. The department will continue its mosquito control work to further reduce the risk of transmission of chikungunya fever (CF) and dengue fever (DF).

     In September, all 64 survey areas recorded an area gravidtrap index (AGI) lower than the alert level of 20 per cent. The decreases in the MGI and the AGI are attributable to the continuous and intensified mosquito prevention and elimination operations by various government departments and stakeholders, and may also have been affected by factors such as weather. The monthly rainfall was 528.7 millimetres in September, showing a decrease from the 939.2mm in August and 601.7mm in July. Overall, the MGI for Aedes albopictus mosquitoes in September was 2.5 per cent, at Level 1 (indicating the distribution of Aedes albopictus mosquitoes in the survey areas was not extensive). Relevant departments and stakeholders will persistently intensify mosquito prevention and elimination operations.

     Moreover, the monthly density index for Aedes albopictus in September was 1.1, which represented that an average of 1.1 Aedes albopictus adults were found in the Aedes-positive gravidtraps, indicating that the number of adult Aedes albopictus was not abundant in the survey areas.

     The FEHD currently makes regular announcements on gravidtrap indexes for Aedes albopictus on its webpage. To allow more citizens to quickly grasp the mosquito infestation situation, the FEHD has strengthened information dissemination by promptly announcing the latest gravidtrap indexes through press releases and social media.

     In addition, to further reduce the risk of transmission of CF, the FEHD has extended the intensified mosquito control work, which was originally activated when the AGI reaches 20 per cent, to cover areas with the AGI falling between 10 and 20 per cent. Specifically, the FEHD will conduct detailed risk assessments in the areas concerned to identify locations with higher mosquito infestation risks and, in collaboration with relevant departments and stakeholders, conduct intensive and targeted mosquito control work. The FEHD will also notify nearby housing estates, advising property management agents and residents to stay vigilant and work together to take mosquito prevention and elimination measures.

     To reduce the risk of transmission of CF and DF, the FEHD continues to step up mosquito prevention and control measures across all districts and to conduct vector investigations and targeted mosquito control operations within a 250 metre radius of the residence of patients and the places patients had visited during the infectious period, including removing mosquito breeding grounds, applying larvicides to stagnant water that cannot be cleared, and carrying out ultra-low volume fogging operations in adult mosquito habitats such as densely wooded areas, dark and secluded places, and abandoned structures to eliminate adult mosquitoes.

     The FEHD continues to conduct its three-phase Anti-mosquito Campaign this year. The third phase of the territory-wide campaign was launched on August 4 and will run until October 24. During the period, the district offices of the FEHD will target areas that have drawn particular concern, such as public markets, cooked food centres and hawker bazaars, single-block buildings, streets and back lanes, common parts of buildings, village houses, construction sites, vacant sites and road works sites to remove accumulated water and carry out mosquito prevention and control work. To further enhance the effectiveness of mosquito control, the FEHD and relevant government departments have carried out phase two of the All-out Anti-mosquito Operations from May 7. In addition to the work of phase one, including eliminating potential mosquito breeding places, the FEHD called on property management entities to arrange for necessary repairs to their premises to minimise mosquito breeding places and commence adult mosquito control measures by means of regular ultra-low volume fogging operations.

     The FEHD appeals to members of the public to continue to stay alert and work together to carry out mosquito prevention and control measures early, including inspecting their homes and surroundings to remove potential breeding grounds, changing water in vases and scrubbing their inner surfaces, removing water in saucers under potted plants at least once a week, and properly disposing of containers such as soft drink cans and lunch boxes. The FEHD also advises members of the public and estate management bodies to keep drains free of blockage and level all defective ground surfaces to prevent the accumulation of water. They should also scrub all drains and surface sewers with an alkaline detergent at least once a week to remove any mosquito eggs.

     Aedes albopictus is a kind of mosquito that can transmit DF and CF. DF is commonly found in tropical and subtropical regions of the world, and has become endemic in many countries in Southeast Asia. In 2024, the World Health Organization (WHO) recorded over 14 million cases, which was a record number. Additionally, according to the WHO, CF cases have been recorded in more than 110 countries/regions. Many countries worldwide experienced CF outbreaks this year, and as of August, over 317 000 cases had been reported in 16 countries/regions worldwide. The DF and CF activities in neighbouring areas have remained high. Members of the public should stay vigilant and continue to carry out effective mosquito prevention and control measures.

Lands Department issues two pre-sale consents in third quarter of 2025

Source: Hong Kong Government special administrative region – 4

     The Lands Department (LandsD) announced today (October 8) that two pre-sale consents for residential developments involving 1 851 residential units were issued in the third quarter of 2025.

     Details of the above residential developments with pre-sale consents issued are as follows:
 

Expected year of completion Developments
2025
  • One development in Sai Kung (51 units)
2028
  • One development in Kai Tak (1 800 units)

 
     The LandsD also issued two consents to assign in the third quarter, involving a total of 87 residential units in two phases of a development in Kowloon Tong.

     As at September 30, 2025, 29 applications for pre-sale consent for residential developments involving 8 902 residential units were being processed. Details are as follows:
 

Expected year of completion No. of applications No. of residential units involved
2026 10 2 832
2027 13 3 563
2028 6 2 507

 
     In addition, 10 applications for consent to assign involving 3 666 residential units and four non-residential units respectively as well as three applications for pre-sale consent for non-residential developments were being processed.

     Members of the public can obtain up-to-date information on consents issued for the past quarter and cases pending approval by visiting the LandsD website (www.landsd.gov.hk).

     Intending purchasers are advised to study carefully the details of the development and the sale procedures, through information available from public advertisements, sales brochures and price lists released by the developer, before making a deposit for purchase. The sales brochure for a development also contains a summary of the provisions of the Deed of Mutual Covenant, including information on the common parts, the number of undivided shares assigned to each unit, the term of years for which the manager is appointed, the basis on which the management expenses are shared among the owners of the units, as well as a summary of the provisions of the government land grant, which intending purchasers are recommended to read carefully.

LCQ8: Prevention of herpes zoster

Source: Hong Kong Government special administrative region – 4

     Following is a question by the Hon Benson Luk and a written reply by the Secretary for Health, Professor Lo Chung-mau, in the Legislative Council today (October 8):

Question:

     It is learnt that there are at present over 80 recognised autoimmune disorders, with as many as 30 000 patients in Hong Kong suffering from such disorders who are at greater risk of contracting herpes zoster (HZ) (commonly known as “shingles”) than average persons. While various forms of HZ vaccination plans (commonly known as “shingles vaccine”) are available at various prices in the private healthcare market, the charges are considerable, with ordinary medical groups charging no less than HK$5,000. Yet the vaccine provides effective protection for only 10 years and revaccination is necessary afterwards. Ordinary grass roots may not be able to afford the expenses. In this connection, will the Government inform this Council:

(1) given that HZ vaccine is currently not included in the Government Vaccination Programme, and that in its reply to a question raised by a Member of this Council on November 20 last year, the Government indicated that the Scientific Committee on Vaccine Preventable Diseases considered that more local data from a cost-benefit analysis would be required for future consideration on whether to include HZ vaccine in the Government Vaccination Programme, whether relevant reviews have been conducted by the authorities; if so, of the details and the outcomes of the latest review; if not, the reasons for that;

(2) as it is learnt that it is more difficult for patients with autoimmune disorders than average persons to ascertain whether they have HZ because they may often experience unknown pain, redness and various inflammations, and as a result these patients have to spend considerable time and expenses to identify the cause of their ailments, whether the authorities have formulated any established mechanism to assist such patients in early detection and treatment of HZ; if so, of the details; if not, the reasons for that; and

(3) in the long term, whether the SAR Government will consider including HZ vaccine in its Vaccination Programme when its public financial resources return to a sufficient level, so that grass-roots patients with autoimmune disorders or other high-risk individuals can receive subsidised vaccination services?

Reply:

President,

     Herpes Zoster (also known as Shingles) is caused by varicella-zoster virus, which is also responsible for Chickenpox. The virus remains latent in the nervous system of patients recovered from Chickenpox and may reactivate in times of weakened immune system many years later, inducing Herpes Zoster. Therefore, Herpes Zoster is not a disease caused by acute infection. Patients would develop painful, belt-like skin rash with blisters. Herpes Zoster is not serious in general and the risk of serious complications or death is not high. Early treatment with antiviral medications can speed up the healing of blisters; reduce the symptoms and the risk of complications. 

     One of the preventive measures against Herpes Zoster is to receive Herpes Zoster vaccine. Currently, there is one Herpes Zoster vaccine registered in Hong Kong. According to international literature available so far, the effective protection period of Herpes Zoster vaccines is around ten years generally.

     The Scientific Committee on Vaccine Preventable Diseases (SCVPD) under the Centre for Health Protection (CHP) of the Department of Health (DH) regularly reviews the epidemiological situation of local vaccine-preventable diseases, the latest recommendations of the World Health Organization (WHO), scientific developments and evidence on vaccines, updates on vaccine components, cost-effectiveness studies, as well as actual experiences of other health authorities, and provides relevant vaccination recommendations to the DH from a public health perspective. The Government will make reference to the recommendations of the SCVPD and carefully consider various factors, including the overall medical burden of a disease on the community, vaccine availability, cost-effectiveness of large-scale vaccination, public acceptability, and other public health factors, in formulating various government subsidised immunisation programmes.

     For vaccines not included in the government’s subsidised immunisation programmes, individuals can consult their family doctor for professional advice to understand the benefits, risks and necessity of vaccination. Based on the doctor’s assessment of health status, medical history, and other factors, individuals can make informed decisions on whether to proceed with vaccination under informed consent.

     In response to the Hon Benson Luk’s question, Health Bureau’s reply after consultation with the DH and the Hospital Authority is as follows:

(1) and (3) The SCVPD discussed the topic of Herpes Zoster vaccines in September 2023. It considered that more local data from a cost-benefit analysis perspective would be essential for future consideration on the inclusion of Herpes Zoster vaccine into the government’s vaccination programme. The SCVPD was of the view that Herpes Zoster vaccines available in Hong Kong were safe and effective. Individual older adults and adults with immunocompromised conditions may consider receiving Herpes Zoster vaccine after consulting their doctors to protect themselves against Herpes Zoster and its complications.

     The Health Bureau has commissioned The University of Hong Kong to conduct an analysis on the cost-benefit of the Herpes Zoster vaccine. Upon completion of the cost-benefit analysis, the SCVPD is expected to discuss the vaccination for Herpes Zoster based on the relevant analysis results in 2026.

     The Government will continue to closely monitor relevant factors, including the latest recommendations of the WHO, the views of the SCVPD, the development and change in costs of vaccines, and the overall medical burden of the disease to consider whether to implement a government-subsidised Herpes Zoster vaccination programme. The subsidy level targeting different groups will also need to be considered if it is necessary to implement the programme.

     Moreover, at the primary healthcare level, family doctors and primary healthcare professionals will closely collaborate to provide information and education on vaccinations (including Herpes Zoster vaccine), to enhance public awareness of the Herpes Zoster vaccine and preventive consciousness.

(2) As mentioned above, Herpes Zoster is not serious in general and the risk of serious complications or death is not high.    

     Patients with Herpes Zoster first experience itch or slight pain with burning sensation in the affected area, with rash appearing one to three days later. The rash then develops into blisters, which further spread in a belt-like pattern and can last from one to 14 days, during which pustules or trickle of blood may appear. This will be followed by bursting, collapse and drying up of the fluid-filled blisters and crusting over two to three weeks. Antiviral drug can shorten the recovery time of Herpes Zoster patients and it is optimal to take it within three to five days of the onset of the disease.  

     The Government encourages the public, especially immunocompromised individuals to remain vigilant. Members of the public, who experience symptoms, should seek medical advice early and take medications according to doctors’ instructions. At the same time, the Government is committed to enhancing district-based primary healthcare services to shift the emphasis of the present healthcare system and mindset from treatment-oriented to prevention-oriented. Initiatives include promoting the Life Course Preventive Care Plan through District Health Centres to formulate personalised health management plans that address the health needs of citizens across different life stages, based on personal factors such as their gender, age and family history. The Government provides chronic disease and cancer screening, as well as advice and education on healthy lifestyle through family doctors and primary healthcare professionals, with a view to improving the overall health conditions of the citizens. The Government also takes this opportunity to remind the public that maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help strengthen immunity and prevent Herpes Zoster.